SER Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - AgeX Therapeutics Inc

Watchlist Manager

Watchlist

Price: 2.65 USD -2.57%

Market Cap: $39.8m

A	AgeX Therapeutics Inc AMEX:SER	US
P	Pacific Silk Road Resources Group Inc XTSX:PP	CA
	NPR Finance Ltd BSE:530127	IN
E	Esso Thailand PCL SET:ESSO	TH
	Fermiere du Casino Municipal Cannes SA PAR:FCMC	FR
V	Vraj Iron and Steel Ltd NSE:VRAJ	IN
P	Pentapro Materials Inc TPEX:7887	TW
C	Ceridian HCM Holding Inc F:CQL	US
T	Topdanmark A/S DUS:TQ71	DK
	Nutriband Inc NASDAQ:NTRB	US
	Clabo SpA MIL:CLABO	IT
	Caisse Regionale de Credit Agricole Mutuel de Normandie Seine SC PAR:CCN	FR
	Exopharm Ltd ASX:TYP	AU

Profitability Summary

AgeX Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Sustainable 3Y Average Gross Margin

14%

Negative Operating Margin

-18 478%

Negative 3Y Average Operating Margin

-11 975%

Declining Operating Margin

-18 450% > -18 478%

Negative Net Margin

-14 755%

Negative 3Y Average Net Margin

-10 442%

Net Margin is Increasing

-27 725% > -14 755%

Negative Free Cash Flow Margin

-13 857%

Negative 3Y Average Free Cash Flow Margin

-11 669%

Free Cash Flow Margin is Increasing

-16 100% > -13 857%

Negative ROE

-6 352%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-819%

Declining ROIC

-112% > -1 126%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.